AlphaTON Announces LOI Between ustralia's Asbestos and Dust Diseases Research Institute And Tarus Therapeutics To Conduct Investigator-Initiated Mesothelioma Clinical Trial of TT-4

AlphaTON Capital -4.49% Pre

AlphaTON Capital

ATON

0.39

0.39

-4.49%

+0.31% Pre
AlphaTON Announces LOI Between ustralia's Asbestos and Dust Diseases Research Institute And Tarus Therapeutics To Conduct Investigator-Initiated Mesothelioma Clinical Trial of TT-4
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via